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Background: Researchers have widely documented the pervasiveness of HIV stigma and discrimination, and its
impact on people living with HIV. Only a few studies, however, have analysed the perceptions of women living
with HIV accessing sexual and reproductive health (SRH) services. This study explores the experiences of stigma of
HIV-positive clients attending family planning and post-natal services and implications for service use and antiretroviral
therapy (ART) adherence. Our aim was to gain a better understanding of the impact of various dimensions of stigma
on service use and ART adherence among HIV clients in order to inform the response of integrated SRH services.
Methods: In-depth interviews were conducted with 48 women living with HIV attending SRH services in two districts
in Kenya. Data were coded using Nvivo 8 and analysed using a thematic analysis approach.
Results: Findings show that many women living with HIV report high levels of anticipated stigma, resulting in a desire
to hide their status from family and friends for fear of being discriminated against. Many women feared desertion
following disclosure of their positive status to partners. Consequently some women preferred to hide their status and
adhere to HIV treatment in secret. However, the majority of study participants attending postnatal care (PNC) services
also revealed that anticipated stigma does not adversely affect their HIV drug uptake and ART adherence, as their drive
to live outweighs their fear of stigma. Our findings also seem to suggest a preference for specialist HIV services by
some family planning (FP) clients because of better confidentiality and reduced opportunities for unwanted disclosure
that could lead to stigma.
Conclusions: The findings highlight that anticipated stigma leading to low disclosure is widespread and sometimes
reinforced by health providers’ actions and facility layout (contributing to enacted stigma). However, the motivation to
stay healthy and look after the children appears in many cases to override fears of stigma related to ART adherence in
our client-based sample.
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In sub-Saharan Africa, women remain disproportionately
affected by the HIV epidemic, accounting for 58% of all
people living with HIV in the region [1].
Researchers have widely documented the pervasiveness
of HIV stigma and discrimination at community level, and
its impact on accessing HIV prevention and treatment [2],
and care and support services [3]. It can also create barriers* Correspondence: manuela.colombini@lshtm.ac.uk
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article, unless otherwise stated.to the use of condoms and uptake of HIV testing and
prevention of mother to child transmission programs
(PMTCT) as well as other services (such as legal, employ-
ment, psychosocial care) [4,5]. A study in rural Kenya sug-
gests that HIV-related stigma is associated with a low rate
of delivery by skilled attendants [6].
Existing theoretical research on HIV-related stigma
also highlights how various aspects of stigma negatively
impact on healthcare access, and health outcomes [7,8],
and is associated with stress, depression, and lower per-
ceived quality of life among people living with HIV [9].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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enacted stigma (actions resulting from stigma, also known
as discrimination), anticipated stigma (fear that stigma will
be experienced) and internalised stigma (the internalisation
of the negative or devaluing attitudes) [10-15]. HIV-related
stigma and discrimination can manifest themselves in dif-
ferent ways: through prejudice, negative attitudes, abuse
and maltreatment directed at people living with HIV.
Several studies have analysed the perceptions of stigma
among women living with HIV (WLWH) accessing ante-
natal and PMTCT services [16-19], though little has been
documented about experiences of stigma by family plan-
ning (FP) and post-natal care (PNC) clients and its service
implications. This study sought to explore the perceptions
of stigma among clients living with HIV attending FP and
PNC services in Kenya. Our aim was to gain a better un-
derstanding of the implications of various dimensions of
stigma on service use, breastfeeding practices and ART
adherence among HIV clients in order to inform the re-
sponse of integrated SRH services.
Methods
Sites
This study was conducted with women attending nineteen
public health facilities, including 1 provincial hospital, 8
district hospitals, 6 sub-district hospitals and 4 health cen-
tres from urban and rural areas of Central and Eastern
Provinces in Kenya. Nine of these facilities offer integrated
on-site HIV and PNC services: mostly HIV counselling
and testing and antiretroviral therapy (ART) referral at
MCH. After six months post-partum, most women are
transferred (from PNC) to HIV clinics for their own HIV
treatment and care. Eight facilities offer integrated HIV
and FP services: HIV/STI counselling and testing services
in the same FP consultation room, and referral to on site
Comprehensive Care Centres (CCCs – specific HIV clinics)
for specialised management.
Central and Eastern provinces have HIV prevalence
levels in women age 15-49 between 3% and 5% overall, ex-
cept North Eastern province where the prevalence is about
1 percent [20].
Ethical approval for this study was obtained from the
Kenya Medical Research Institute (approval nos. SCC/
113 and SCC/114), from the London School of Hygiene
and Tropical Medicine (approval no. 5426), and from the
Population Council Institutional review Board (approval
nos. 443 and 444).
Participants and procedures
This articles draws on a total of 48 qualitative in-depth
interviews (IDIs) with HIV-positive women. Semi-structured
interviews were conducted with women living with
HIV attending SRH services in Eastern and Central
Provinces. The sample – originally recruited from healthfacilities - was randomly selected from a larger cohort of
HIV-positive women who participated in a study on in-
tegration of family planning and HIV services in Kenya
and Swaziland [21]. In order to maintain geographical
representation (to gather information across sites in
the 2 Provinces), a sample of women was selected from
nineteen study facilities. Face-to-face interviews were
conducted in Kiswahili by 8 trained local interviewers
between January and March 2011. IDIs were conducted in
private locations preferred by the interviewees, primarily
homes. No interviews took place in health facilities. Writ-
ten informed consent was obtained from all participants
before they were interviewed. In-depth interviews were
designed to take approximately an hour to complete. All
interviews were audio-recorded.
Interview guides
A semi-structured topic guide was designed to elicit in-
formation on women’s experiences of SRH services they
visited (and from where they were recruited), and their
views and perceptions of stigma at health facility and
community levels. The final guide was comprised of nine
main parts with opening questions and probes for each
section to help explore issues in-depth. Main topics -
originally pre-determined based on the study objectives
and on the quantitative findings we wanted to explore
in-depth - covered included stigma, process and outcomes
of disclosure, adherence and potential fear of disclosure;
breastfeeding practices and challenges; discrimination by
health providers.
Data analysis
Audiotapes of the interviews were transcribed in Kiswahili
by the local interviewers and translated to English. Data
were analysed using a thematic analysis approach [22].
Data were coded using the Nvivo 8 software. Initial coding
of the transcripts was conducted by the first and last au-
thors according to major topics from the interview guides,
but new codes and themes were also developed based
on the interviews’ data. Quotations, relevant passages
and memos regarding each topic were brought together
into matrices, organised into categories and sub-categories,
and analysed to identify common themes and variant
views. The hierarchy of codes was constantly adjusted and
refined during the analysis process, until fewer broad over-
arching themes were identified. Measures to ensure valid-
ity of the results included discussion of preliminary results
with local partners working in SRH in Kenya.
Results
Table 1 presents the socio-demographic characteristics
of the 48 study participants. We explored how stigma
was perceived and experienced by WLWH and what the
main effects of this seemed to be. This section is divided
Table 1 Socio-demographic characteristics of the study
participants





















both (of us) 0 (0)
other 4 (8)
Number of living children:
0 = 1 (2)
1 = 5 (10)
2 = 14 (29)
3 = 12 (25)
4 = 8 (17)
5 & over = 8 (17)
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at health service level; second, the effects of stigma on
low disclosure of HIV status and specifically on, breast-
feeding and ART adherence as two behaviors that are
significantly affected by lack of disclosure.
The majority of women in our study reported antici-
pated stigma, while only a few reported enacted stigma.
There were few differences between FP and PNC clients
(where they exist they are reported), primarily linked to
breastfeeding dilemmas and ART adherence.
Experiences of stigma at health facility level
The majority of women interviewed reported anticipated
stigma. Most of the study clinics observed offeringintegrated FP and HIV services have audio-privacy dur-
ing consultations, and women were seen alone and
asked questions in complete privacy. However, some re-
spondents attending family planning services stated that
they feared people would discover their status just by at-
tending the facility’s services. Some mentioned they did
not feel free because the physical space of the hospital’s
clinic was too open, thus leading to lack of privacy and po-
tential involuntary disclosure.
“I: And do you feel comfortable here at the clinic?R: They have exposed us so much…[…] The place is
too open.[…]: Everybody…when they come in, they see
us. At least we would like somewhere hidden....I don't
feel free.” [FP 010476]
On the other hand, one FP client said she chose her
clinic because nobody knew her: ‘because I’m not known
there so much’ [FP 06 08 02].
One PNC client also mentioned that she would rather
travel further than to be transferred to another hospital,
because she liked the doctors in her [HIV] clinic and she
feels ‘free’.
“R: those doctors, those who treat us at X [name of
community/clinic] [are friendly], which is why when
another day they told me they would give transfer
to Y [name of community/clinic] I told them I
would rather pay that fare [higher fare to go to X
clinic] and go to X [name of community/clinic].
They are friendly, and they give you the chance to
ask the questions that you want. There you are
free.” [PNC 140433]
Interestingly, lack of trust in maintaining confidential-
ity by the health providers was only mentioned as a chal-
lenge by some FP clients, and not by PNC ones. One
woman said she would prefer to have one single provider
treating her because she would fear others may “spread”
her status (as she would have to disclose it to new health
providers every time they change).
“I: the reason for being attended by that one provider?R: Because it’s him/her who understands me, yes. It’s
him/her who knows my status. If I am sent to
someone else….to another doctor [who does not
know my status] I am scared to say, to tell him/
her… because, I see as if he/she may spread
[the information about my status].” [FP 060802]
Changing of providers for every service was also said
to have an impact on clients’ disclosure.
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remains [offering] family planning every day you meet
him/her, because you’ll be able to explain your
problem. […] But if you find a different person [every
time you go for FP] you will wonder ‘now where will I
start to explain to this one’. […] Maybe someone is
afraid. You know, you can’t tell someone private issues
when you have just met. Maybe, if you are free with
each other… that is why I am saying: if you meet him
[provider] today and meet him again next time,
maybe you will be free [to talk] to each other and you
will be able to tell them.” [FP 11117]
Some FP clients said it was good to be separate from
‘other people’ [not infected] because there was no fear of
involuntary disclosure and therefore they felt free; and
found mutual support from others because they were all
positive.
“While inside [the CCC: comprehensive care centre]
we feel free…because not many people know what
kind of people these are. It is not the way it was
there… [..] The time I was in the hospital, I had fears
and that is why some people did not want to be
identified. Because when someone sees you [there at
the clinic], they say that that person is sick. But on
this side we know each other… We think the
separation is good, even when you tell someone they
don’t fear, there’s no secrecy because you are telling
them, all of us here are with one [same] condition”.
[FP 041649]
Although the PNC clients interviewed had not
expressed a clear preference for separated services, one
woman mentioned the benefits of being able to ‘ex-
change ideas’ and advice with other positive women.
Interestingly, many of the PNC clients started their HIV
services (PMTCT) at ANC and PMTCT clinic.
Only one PNC client reported an experience of enacted
stigma at a health facility: just after delivering her baby she
experienced involuntary disclosure due to lack of protec-
tion of confidentiality while at the facility. We consider
lack of confidentiality/privacy leading to unwanted disclos-
ure as a form of enacted stigma.
“R: I had to tell her [mother in law], she is the one
who took me to the hospital and she was there when I
was giving birth. She knows that a woman is supposed
to breastfeed after she has given birth, something she
never saw happening because I was told not to
breastfeed the baby and saw the service provider
administering some drugs to the baby and she could
not understand what was happening and therefore I
had to tell her the truth.”[PNC 011463]Effects of stigma on low disclosure
One of the main emerging themes was how stigma influ-
enced low disclosure among WLWH. In our study of
stigma ‘fears’ were also a key factor influencing women’s
behavior on disclosure: fear of discrimination.
More than half of the women in the study disclosed their
HIV-positive status only to their close family (mother,
sister or father) for fear of being discriminated against be-
cause of negative community beliefs about people living
with HIV. Anticipated stigma following disclosure was
quite prevalent among all women in the study. Many said
they were afraid to disclose their status because they feared
others would start gossiping about them.
“R: I am afraid of the others, you can tell someone
then he starts talking badly, begin to go tell and tell
others”. [PNC 131530]
Some women who reported not having disclosed their
status said that they feared being blamed by relatives for
having transmitted HIV to the partner even if he was
the one who was infected first.
“I: So why have you not told him?
R: Now it is that fear. I do not have a way of explaining
to him.
I: Ehe? What are you afraid of?
R: t … that his parents know me, and they do not
know about my status, they may say: ‘Our son was
infected by that girl’, I do not know what… Mm. And it
may be possible that he is the one who … infected me.
No one knows who infected the other”. [PNC 140433]
Over a fifth of the respondents cited a certain degree of
fear of partner’s rejection and/or negative reactions. In par-
ticular, five women cited the fear that someone else could
tell their husbands they are ill and, as a consequence, the
husband might either leave them or abuse them.
“I: And why haven’t you told anyone else?
R: They [people] can do bad things to you […]. They can
tell my husband. […] If my husband got to know about it
[that she is positive] he will be mad with me and
quarrel […] He can tell me to go back home so that [we]
separate. I don’t want that to happen”. [PNC 027126]
For some of the women who disclosed to their husband
or partner, these fears of abandonment became real.
“I: How did he know?
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[FP 050435]
Although there were no reports of physical violence
following disclosure of HIV-positive status, four reported
that the husbands had initial negative verbal outbursts
and blamed them for bringing the “disease” home.
“He abuses me, he says he will look for another wife
[…] he did not beat me”. [FP 010247]
All of the women who had disclosed their status stated
they feared disclosure and its potential consequences.
Among the reasons stated for disclosing to only one or
very few people were: fear of being rejected, isolated and
not helped; fear of being blamed; fear that people may
disclose their status to others.
“R: I told them [family] only recently.
I: Okay. . . Who did you tell first?
R: My mother […] I felt bad. […] I thought they will
discriminate me take… me negatively […] I mean . . .
they will stop helping me. . .”. [PNC 140357]
Nevertheless disclosure was also found to have positive
effects, particularly among PNC clients. Among the
women who disclosed their status, nearly a third cited a
positive outcome following disclosure to their husband/
partner, especially if both partners were HIV-positive.
Couple counseling and testing and condom use were
most often mentioned.
“I told my partner so that he also knows his status
[being advised by doctor to disclose to husband and
get couple VCT]. As a result, my husband went and
he was found positive.” [PNC 140624]
Stigma and breastfeeding among PNC clients
In the past few years, Kenyan clinical practices seem to
have given mixed messages to both health workers and
WLWH about breastfeeding. As a result, educational
messages highlighting the positive health benefits of ex-
clusive breastfeeding have not fully reached the health
providers and the women on the ground.
This section focuses primarily on PNC women. FP cli-
ents were not asked about breastfeeding directly. Several
PNC women reported that anticipated stigma (and the
fear of involuntary disclosure) affected their breastfeeding
practices. All the PNC respondents said they received clin-
ical advice on exclusive breastfeeding for at least 6 months.
Only 2 women were advised not to breastfeed the baby
and use formula milk instead. Although some womenmanaged to breastfeed their baby for at least 6 months, it
seems that despite the advice received, many PNC women
breastfed for only few weeks or months and then stopped
because they were still afraid of transmitting the virus to
their baby, or because they got sick. Several respondents
mentioned they feared that others, such as neighbours or
relatives, may gossip about them if they knew they were
not breastfeeding their baby. A few reported that people
would check whether a woman was breastfeeding or not
in order to detect someone’s status.
“I hear many gossiping and saying “so and so had the
virus and is giving birth. Why is she giving birth?”
They even follow her to the house to see if she is
breastfeeding. If they find she is not breastfeeding they
go away and say she has the virus. […] they are saying
she is giving the virus to the children”. [PNC 070222[1]]
For these reasons, some women said they hide the fact
that they were not breastfeeding because they feared
people would think they were positive.
“Even at this moment no one knows that I don’t
breastfeed.[laughs] You just know how people talk?
They start gossiping about you. Even if they knew, I
did not want to show them myself.” [PNC 131547]
One respondent also mentioned how she feared people
would think less of her if she revealed she stopped
breastfeeding her baby.
“I: why have you kept it a secret to them that you are
not breastfeeding your child?
R: I do not want them to know …..If they do…will go
around saying things here and there… [They] will see me
as a foolish person…. They will be seeing me as a person
of no importance”. [PNC 0105124]
Even women who were still breastfeeding reported
some fear of being stigmatised by the community if they
stopped breastfeeding.
“I won’t feel good. They can hate you, they can gossip
about me, they start talking about me badly [if they
know I stopped breastfeeding].” [PNC 140448]
Only one woman reported how the breastfeeding advice
she got at the clinic helped her focus on her individual
choice rather than being influenced by any external fac-
tors. This also helped her overcome her fear of stigma.
“I would not feel discriminated if I do not breastfeed
my baby… because we were attending the teachings [at
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that ‘this time, it is your responsibility, you can choose
for yourself the feeding method you want to use to
raise your baby with’…these are the things I can tell
others [members of community who question her
breastfeeding practices]’. [PNC 081105]
Stigma, secrecy and ART adherence
This section reports findings primarily for PNC clients,
as the majority of FP clients were not directly asked
about adherence and/or did not reveal whether or not
they were on antiretrovirals (ARVs).
No reports of enacted stigma related to drug uptake
emerged from the findings. The majority of women inter-
viewed mentioned experiences of anticipated stigma. Of
the fifteen PNC respondents who said they were on ARVs
only two women said they take their ARVs in secret be-
cause they have not disclosed their positive status and they
fear that people and/or their husband would realise they
are ill if they are seen taking pills.
“I: You told me that your husband has no knowledge
that you are using these drugs? How do you take these
drugs?
R: I put them in my pocket. […] He doesn’t come checking
my pocket […] I wait for him to go”. [PNC 0207126]
Others said they were sometimes afraid to take their
medications for fear of others finding out their status.
“R: When there are people [it is hard to take ARVs]
because I have not told them. Now if they see me
taking medication? They will ask why I am taking
medication; they will ask why I am taking
medications … like when I had not told my husband
that I wasn’t even taking them…because I was
hiding from him so he could not to see them.”
[PNC 070222]
Although we do not have information on actual adher-
ence, most of the women reported that they were taking
their ARVs even if they did not disclose their status and
showed high motivation for adherence. One woman said
that she would always find a way to take her pills even if
she did not tell her husband.
“I: Earlier you told me no one knows you are using these
drugs. If your husband does not leave, would you take
the medicine?
R: He cannot make me not take my medicine. I will
hide and take it. … I will always find my way out”.
[PNC 0207126]Many said that ARVs made them live longer and feel
better and they can take care of their children.
“You know if you use those medications, it helps
you to live longer. […] If you don’t use them, you
will not fare [feel] well. […] I felt it was proper to
use so that I can take care of my children”.
[PNC 091237]
Discussion
The article explored how stigma was perceived and ex-
perienced by women living with HIV and what the main
effects of this seemed to be on their lives. Only a few
women in the study reported experiences of enacted
stigma, primarily being abandoned by husbands. Only one
report was mentioned of enacted health facility stigma.
The low disclosure of experiences of actual discrimination
could be the result of courtesy bias, where the respon-
dents, who were originally recruited in health facilities,
may perceive the interviewers as part of the medical team.
However, as we did not interview them at the facilities,
but at a place of their choice (usually home) and they had
already taken part in a survey questionnaire, we believe
that such bias was minimised.
The main type of stigma evident among our respondents
was anticipated stigma from community and family mem-
bers, particularly husbands or partners. Some differences ap-
peared between FP and PNC clients in relation to reported
preferences for integrated services by FP clients, reported
adherence levels among PNC women, and breastfeeding di-
lemmas experienced by PNC clients.
The study suggests that fear of stigma (i.e. “anticipated
stigma”) is widespread among the women interviewed.
This fear has several important effects that can lead to
behavioral consequences, such as poor disclosure, unsafe
breastfeeding practices, and reduced ART adherence or
making it more stressful [23,24]. Nevertheless, our find-
ings suggest that the motivation to adhere to drug regi-
mens to protect children and preserve health overrode
the fear of stigma for most of our respondents attending
PNC services. It is an interesting result that seems to
contradict existing literature showing a link between
internalised stigma and ART adherence [25,26]. This
may be due to the fact that this is a specific sample of
women with young children and who are regularly at-
tending SRH services.
Our data show how a number of women feared that if
they disclosed their status they would face negative out-
comes from their partners/husbands or significant others,
including abandonment, separation, verbal abuse, loneli-
ness and loss of financial security. These findings are con-
sistent with other recent research linking HIV stigma to
low disclosure [27-32]. Some of these fears of separation
(and its economic related consequences) and violence
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of stigma described in our study.
Early cessation of breastfeeding and mixed feeding
could increase the risk of HIV transmission to infants,
as recent evidence shows [33]. Recently revised WHO
recommendations are that breastfeeding exclusively for
six months does not increase HIV transmission risk and is
safer for infant health than mixed feeding or formula feed-
ing in situations where formula feeding is not “acceptable,
feasible, affordable, sustainable, and safe” [34]. Our find-
ings suggest that postnatal women’s fear of stigma due to
involuntary disclosure has an impact on feeding prefer-
ences, often resulting in continuation of breastfeeding (des-
pite their fear of HIV transmission to the baby) and stress
caused by feeling the need to hide their status (particularly
in relation to mixed feeding, as the mother-in-law may give
solids or water to the baby before the 6 months threshold).
Other studies have also highlighted how socio-cultural in-
fluences impact on infant feeding decisions among women
living with HIV [19,35-39]. Stigma and inadequate know-
ledge about safe infant feeding are pushing women into
not following the WHO recommendations on exclusive
breastfeeding. The Kenyan guidelines for PMTCT recom-
mend exclusive breastfeeding for the first 6 months and
then to continue breastfeeding up to 1 year with appropri-
ate complementary feeds [40]. However, this advice, which
could help reduce stigma dramatically, has not fully reached
the nurses – and the women - on the ground.
More should be done within healthcare facilities to
ensure that WLWH receive clear information on how
exclusive breastfeeding may achieve lower risks of transmis-
sion. If some of the women interviewed had continued
breastfeeding as recommended, they would not have faced
the stress of stigma (or fear of stigma) from the community.
Some women acknowledged that openly taking their
HIV drugs is a potential risk for involuntary disclosure,
which has also been recognised in other African studies
[41-43]. However, the majority of study participants at-
tending PNC services reported that anticipated stigma
does not adversely affect their HIV drug uptake and
ART adherence. Women’s strong motivation (especially
if they were mothers of young children) to adhere to drugs
and stay healthy for their children appears to outweigh
their fear of stigma. Although this finding could not be
generalised to all other WLWH, ours being a selected
sample of people who regularly attend HIV clinics, it
still seems an important topic to explore further. We
could only find one other regional study reporting that
the maternal desire to protect the child is the main
drive for drug uptake among positive pregnant women
[44]. As stigma is detrimental to women’s emotional
and mental health, further improving it is a crucial (but
neglected) part of achieving better health outcomes for
WLWH. Addressing anticipated stigma, for examplethrough dealing with messaging on safe breastfeeding
and promoting positive support networks, would be a
big contribution to this.
Our study shows that many women attending PNC ser-
vices feared stigmatisation at a health facility. In particular,
the lack of privacy and confidentiality - and limited trust
in service providers’ ability to maintain confidentiality - in-
creases fear of stigma among WLWH attending health
services. Fear of unwanted disclosure can be reinforced by
the providers’ acts and by the health facility settings, as
shown in other recent studies [45-47]. Our data also seem
to reveal that having one provider offering integrated ser-
vices could reduce the fear of repeated disclosure and
improve respect of confidentiality. Our data suggest that
counselling on risks of disclosure and how to cope with
HIV- related stigma is scarce within the selected health
facilities. A study with women attending ANC services in
Uganda shows how women living with HIV felt they did
not receive sufficient counselling after HIV testing to ad-
dress their fears and how to cope with a positive diagnosis
[31]. Health care staff must be sensitive to the fears and
concerns of the HIV-positive mother about their infection,
and issues of disclosure to her partner. Women should be
more supported and receive counselling on the pros and
cons of disclosure (i.e. a balanced and non-judgemental
view) rather than being manipulated or pressured into dis-
closing, and their choice of disclosure (if, when, how and
to whom) should be fully respected.
It is usually argued that integrated services are more
anonymous and confidential than having to be seen going
to a separate HIV clinic and thus less stigmatizing [48-50].
However, our findings seem to suggest a preference for
separate HIV services by some FP clients as they appreci-
ated the freedom to talk and the social support in HIV
clinics, and felt these had better confidentiality from pro-
viders and reduced opportunities for unwanted disclosure
that could lead to stigma. This finding contributes to a
small literature supporting this view from other studies in
Swaziland and Zambia [47,51].
The study results support the importance of strength-
ening health education sessions on safe breastfeeding
practices and of integrating psychosocial support services
for HIV-positive women – whether on site or off-site –
into existing SRH and HIV services. The newly adopted
Kenyan Minimum Package for Reproductive Health (RH)
and HIV Integrated Services incorporates psychosocial
support as an essential element of its package [52]. Pro-
viders at maternal health and child health (MCH) and
Family planning (FP) units should be able to refer HIV-
positive women to psychosocial support that could help
reduce anticipated and internalized stigma. Moreover, the
friendliness of health professionals and making clients feel
they have the freedom to talk and ask questions has been
proven to be an important characteristic for client
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HIV and PNC or FP services.
Limitations
Being a qualitative study with a relatively small sample it
is not possible to generalize the findings. It should also
be acknowledged that these findings are based on what
the women interviewed chose to report to the interviewer,
and we do not have data about their actual adherence or
breastfeeding practices. Moreover, this is a group of
women attending health services and thus their responses
may not be reflective of all women of reproductive age
living with HIV.
Conclusions
Many women in our sample reported anticipated stigma,
although only a minority experienced enacted stigma.
Anticipated stigma was found to be exacerbated by the
actions of providers and by a lack of accurate or consistent
information on safe breastfeeding practices. Anticipated
as well as enacted stigma can lead to low disclosure,
low ART adherence and unsafe breastfeeding practices.
It is therefore important to tackle anticipated stigma,
including through improving accuracy of information
on safe-breastfeeding and improved confidentiality of
clients using services. In particular some respondents
noted that having a single provider (with whom trust is
built over time) could decrease stigma and fear of involun-
tary disclosure. A number of women indicated preferences
for specialist HIV sites for multiple service provision and
this should be explored in further research.
Despite women’s fears of stigma we also found an
overwhelming drive to adhere to their drugs in order to
remain healthy and look after their children. This is a
powerful motivation that should be built on through
messaging on safe breastfeeding and promoting positive
support networks.
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